Abbott MediaRoom - Press Releases

Jan 19, 2019

New Data Reinforce Benefits of Abbott’s BurstDR™ Spinal Cord Stimulation for People Living with Chronic Pain

- Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR™ stimulation
- Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices
- Additional data further showed switching from other types of SCS therapies to Abbott’s BurstDR stimulation significantly reduced pain and the need for opioid medication

Show per page

true

accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

yes no

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

yes no

accessibility

Asset Warning

yes no

PRESS RELEASES

You are about to exit for another Abbott country or region specific website

Do you wish to continue and exit this website?

You are about to exit the Abbott family of websites for a 3rd party website

Do you wish to continue and exit this website?